Masumi Ueda Oshima, MD MA (@masumi_ueda) 's Twitter Profile
Masumi Ueda Oshima, MD MA

@masumi_ueda

ID: 837235833723727874

calendar_today02-03-2017 09:39:12

47 Tweet

154 Followers

290 Following

Brenda M Sandmaier, MD, FASTCT (@sandmaierbrenda) 's Twitter Profile Photo

So grateful for this donation of PPE to Fred Hutch and Seattle Cancer Care Alliance for the use in our patient care! Thank you CCCWA Foundation!

So grateful for this donation of PPE to Fred Hutch and Seattle Cancer Care Alliance for the use in our patient care! Thank you CCCWA Foundation!
Steve Spellman (@spellman_s) 's Twitter Profile Photo

8/8 MUD ptCy > Haplo ptCy. Better matching matters...👇 HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis | Blood | American Society of Hematology ashpublications.org/blood/article/…

Fred Hutchinson Cancer Center (@fredhutch) 's Twitter Profile Photo

Fred Hutch's Clinical Research Division is #hiring an assistant or associate professor in oncology specializing in autologous transplantation and/or #immunotherapy for patients with #MultipleMyeloma. Learn more and apply: apply.interfolio.com/91346 #CareersStartHere

Fred Hutch's Clinical Research Division is #hiring an assistant or associate professor in oncology specializing in autologous transplantation and/or #immunotherapy for patients with #MultipleMyeloma. Learn more and apply: apply.interfolio.com/91346 #CareersStartHere
Masumi Ueda Oshima, MD MA (@masumi_ueda) 's Twitter Profile Photo

I had the great pleasure of interviewing Dr. Rainer Storb for ASTCT Talks Titans of Transplant series! Fascinating stories from the early days of HCT from one of the founding pioneers. Check it out. anchor.fm/astct/episodes…

Masumi Ueda Oshima, MD MA (@masumi_ueda) 's Twitter Profile Photo

Friday morning journal browsing and came across this cool paper from Chris Kanakry lab ⁦NIH⁩. Insights into PTCy’s impact on GVT effects and novel approach to integrate CART cells and allo-HCT👇 ashpublications.org/blood/article/…

Masumi Ueda Oshima, MD MA (@masumi_ueda) 's Twitter Profile Photo

Our paper is out! Higher risk of early CMV reactivation with PTCy, but overall 1-yr viral burden and disease comparable to MTX. MMF associated with higher risk early and late. @zamora_danniel Brenda M Sandmaier, MD, FASTCT Fred Hutch Cancer Center ashpublications.org/bloodadvances/…

Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile Photo

Very important talk at #tandem23 plenary session about inefficiencies in clinic trials - collecting low grade AEs we never use - details of no research use, physical exam details, con meds, - tests of no standard value - mountains of efforts build beacon EPIC EHR builds #bmtsm

Very important talk at #tandem23 plenary session about inefficiencies in clinic trials 
- collecting low grade AEs we never use
- details of no research use, physical exam details, con meds, 
- tests of no standard value 
- mountains of efforts build beacon EPIC EHR builds #bmtsm
Masumi Ueda Oshima, MD MA (@masumi_ueda) 's Twitter Profile Photo

Thank you ASH for the wonderful opportunity to participate in Highlights of ASH Asia Pacific! My highlight: being inspired by new and old colleagues from across Asia Pacific and U.S. Ashley Rosko Alison R. Walker, MD, MPH, MBA Kerry Rogers Robert Brodsky and exploring Hanoi.

Thank you <a href="/ASH_hematology/">ASH</a> for the wonderful opportunity to participate in Highlights of ASH Asia Pacific! My highlight: being inspired by new and old colleagues from across Asia Pacific and U.S. <a href="/Ashley_Rosko1/">Ashley Rosko</a> <a href="/AlisonRWalkerMD/">Alison R. Walker, MD, MPH, MBA</a> <a href="/KerryARogersMD/">Kerry Rogers</a> <a href="/DocsDock200/">Robert Brodsky</a> and exploring Hanoi.
Masumi Ueda Oshima, MD MA (@masumi_ueda) 's Twitter Profile Photo

Come join our Clinical Research Division Fred Hutch Cancer Center in BMT/Immunotherapy! Applications now open for Assistant or Associate Professor in our clinical scholar pathway (50:50 split clinical service: research) 👇 apply.interfolio.com/124473

Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile Photo

1/x Much awaited BMT CTN 1506 trial out in Journal of Clinical Oncology establishing gilteritinib as SOC post #alloBMT maintenance in #MRD +ve FLT3-ITD #AML pts in CR1; thanks to a global collaboration funded by Astellas Pharma US NIH NHLBI and National Cancer Institute to BMT CTN tweetorial👇 ascopubs.org/doi/pdf/10.120…